Evidence map›Paper›PMID 27748053›Full record

ArticleCancer medicine2016

Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment.

Hitoshi Tajiri, Tomoko Takano, Hideo Tanaka, Kosuke Ushijima, Ayano Inui, Yoko Miyoshi, Keiichi Ozono, Daiki Abukawa, Takeshi Endo, Stephen Brooks and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Pediatric Primary Hepatic Tumors: Diagnostic Considerations.Diagnostics (Basel, Switzerland) · 2021
    Review
  6. [Progress in diagnosis and treatment of viral hepatitis in children].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Hitoshi TajiriDepartment of Pediatrics, Osaka General Medical Center, Osaka, Japan.
Tomoko TakanoDepartment of Pediatrics, Osaka General Medical Center, Osaka, Japan.
Hideo TanakaDivision of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Kosuke UshijimaDepartment of Pediatrics, Kurume University Medical Center, Kurume, Japan.
Ayano InuiDepartment of Pediatric Hepatology and Gastroenterology, Saiseikai Yokohama City Tobu Hospital, Yokohama, Japan.
Yoko MiyoshiDepartment of Pediatrics, Osaka University Hospital, Suita, Japan.
Keiichi OzonoDepartment of Pediatrics, Osaka University Hospital, Suita, Japan.
Daiki AbukawaDepartment of Pediatrics, Miyagi Children's Hospital, Sendai, Japan.
Takeshi EndoDepartment of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Stephen BrooksDepartment of Microbiology/Immunology, State University of New York at Buffalo, New York.
Yasuhito TanakaDepartment of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Nagoya City University · JPOsaka Prefectural Medical Center · JPOsaka University Hospital · JPAichi Cancer Center · JPKobe Asahi Hospital · JPKurume University Medical Center · JPMiyagi Children's Hospital · JPUniversity at Buffalo, State University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of the study were to elucidate the clinical characteristics of patients who developed hepatocellular carcinoma (HCC) related to persistent HBV infection since childhood and to investigate usefulness of assessing alpha-fetoprotein (AFP) in this population. A nationwide multicenter survey of children with chronic HBV infection was performed. Among 548 patients, 15 patients developed HCC at the median age of 15 years (range 9-36), including 13 males and 2 females. A case-control comparison showed that HBeAg seroconversion and liver cirrhosis were associated with the occurrence of HCC. Of the 15 HCC patients, 5 were treated with interferon and none of them responded to interferon therapy as compared with 12 of the 17 responders in the control group. Of the 15 patients, 10 died and 9 of the 10 who died never visited any medical facilities until diagnosis of HCC, while the remaining 5 surviving patients never stopped their clinic visits. The usefulness of AFP assessment was shown by the findings that AFP levels were elevated in all HCC cases, that elevations in AFP levels were detected prior to the diagnosis in the surviving patients, and that sensitivity of AFP as a diagnostic test for HCC was very high among 40 patients including our 14 and an additional 26 collected from the literature. HBeAg seroconversion and liver cirrhosis are associated with the occurrence of HCC. Regular measurement of AFP might be helpful to watch for the occurrence of HCC when following children and young patients with chronic HBV infection since childhood.

Indexed as

Biomarkers, TumorAdolescentAdultalpha-FetoproteinsAntiviral AgentsBiomarkersCarcinoma, HepatocellularCase-Control StudiesChildChild, PreschoolFemaleHepatitis B, ChronicHumansInfantInfant, NewbornLiver Neoplasmsalpha-FetoproteinsAntiviral AgentsBiomarkersBiomarkers, Tumoralpha-fetoproteinHBeAg seroconversionhepatocellular carcinomainterferonliver cirrhosis

Identifiers

PMID27748053
PMCPMC5119965
OpenAlexW2538000457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.